17 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
in inflation, along with the uncertainties surrounding any resurgence of COVID-19, geopolitical developments and global supply chain disruptions, have … to regulate pharmaceutical benefit managers (“PBMs”) and other members of the healthcare and pharmaceutical supply chain, an important decision that may
6-K
EX-99
BLRX
Bioline Rx Ltd
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
-readiness activities. We recently completed hiring an experienced sales force, and have substantially advanced supply chain, market access and medical
424B5
1r9v yu4ymn15j1od2
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
81f1gqd
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
g3blpmht0papdxa9ckx
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
i07nevz
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
nog mi6o42wdmvgzvwl
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
fg6km
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
olc 5f72o
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
4o6y6 uh3p3
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
7315aitzvjg az9
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
bdit669i7ewihy
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
zw2ti1h6nn9d0 0d
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
- Prev
- 1
- Next